Literature DB >> 25287311

Daytime sleepiness, sleep disturbance and functioning impairment in bipolar disorder.

Julio C Walz1, Pedro V Magalhães1, Ramiro Reckziegel1, Monise Costanzi1, Larriany Giglio1, Flávio Kapczinski1.   

Abstract

OBJECTIVE: To verify the prevalence and clinical impact of excessive daytime sleepiness (EDS) in outpatients with bipolar disorder.
METHODS: Eighty-one outpatients with bipolar disorder and 79 healthy control subjects were recruited. Patients were required not to be acutely manic or depressed. We used the Epworth Sleepiness Scale, the Pittsburgh Sleep Quality Index and the Functioning Assessment Short Test to assess sleepiness, sleep problems and functioning, respectively.
RESULTS: Patients had a higher prevalence of sleepiness (40%) than the control group (18%). Sleepiness and sleep disturbance had independent impacts on disability in the multivariable model.
CONCLUSIONS: This study suggests that EDS is a relevant clinical dimension in patients with bipolar disorder. It is a frequent symptom that often overlaps with other sleep disturbances. This study also reveals that once present it has the potential to increase functional impairment.

Entities:  

Year:  2013        PMID: 25287311     DOI: 10.1111/j.1601-5215.2012.00673.x

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  4 in total

Review 1.  Recent advances in sleep-wake cycle and biological rhythms in bipolar disorder.

Authors:  Rébecca Robillard; Sharon L Naismith; Ian B Hickie
Journal:  Curr Psychiatry Rep       Date:  2013-10       Impact factor: 5.285

2.  Switching to paliperidone extended release in patients with schizophrenia dissatisfied with previous olanzapine treatment: Post hoc analysis of an open-label, prospective study.

Authors:  Tian Mei Si; Shang Li Cai; Jian Min Zhuo; Li Li Zhang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

3.  Depression and bipolar disorder subtypes differ in their genetic correlations with biological rhythms.

Authors:  Lea Sirignano; Fabian Streit; Josef Frank; Lea Zillich; Stephanie H Witt; Marcella Rietschel; Jerome C Foo
Journal:  Sci Rep       Date:  2022-09-21       Impact factor: 4.996

4.  TRPM2, a Susceptibility Gene for Bipolar Disorder, Regulates Glycogen Synthase Kinase-3 Activity in the Brain.

Authors:  Yongwoo Jang; Sung Hoon Lee; Byeongjun Lee; Seungmoon Jung; Arshi Khalid; Kunitoshi Uchida; Makoto Tominaga; Daejong Jeon; Uhtaek Oh
Journal:  J Neurosci       Date:  2015-08-26       Impact factor: 6.167

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.